Last month, Inpacpen ESP®  has officially entered large-scale commercial production, with an annual capacity reaching tens of millions of units. This milestone positions Innopac as one of the very few companies globally capable of mass-producing energy-stored injection pen systems, further strengthening our leadership in advanced drug delivery devices.

In the field of biopharmaceutical drug delivery systems, every technological breakthrough and capacity expansion injects new momentum into the global pharmaceutical industry. Today, we are proud to announce a major milestone: Innopac’s COC/COP polymer syringe manufacturing platform has reached a total planned capacity of 250 million units per year, including 50 million COP Luer-...

  Innopac  ushered in a crucial moment – by successfully signing a Strategic Memorandum of Understanding (MOU) with EVA Pharma, a leading pharmaceutical company in Egypt!This signing marks a solid step forward in the cooperation between the two parties and lays an important foundation for deepening their partnership in the future. The strong alliance between the two s...

  Recently, our company joined hands with Xinhua Education Foundation to host a "Pearl Students" visit event themed "Love Gathers Strength, Intelligent Manufacturing Strengthens Health"!   Thirty-three students witnessed rigor in the sterile workshop and felt the pulse of growth through dialogues with industry experts. They returned with fruitful gains and sowed seeds of h...

  ?It innovatively integrates a needle protection device that can be activated with a single - handed gentle push, effectively preventing needle - stick injuries and cross - infections for medical staff and waste handlers.Compact and small in design, it conforms to ergonomics, offering a comfortable grip. Its shape adopts the forked concept of an "octopus", allowing for flexible operation....

  The Quality Month campaign is our annual company-wide initiative designed to enhance quality awareness, refine management systems, and continuously improve product and service excellence.    Currently, we have launched a series of activities including quality training sessions, skills competitions, and risk identification programs, supported by dedicated task forces and incent...

  A huge thank you to all industry peers who visited our Booth N5E26 at Shanghai New International Expo Center! INNOPAC made a powerful debut with our cutting-edge drug delivery innovations, engaging in productive dialogues with 100+ domestic and international clients on the precision engineering and patient-centric design of our INPACPEN series.   The snapshots ...

Join Us at C-Beauty 2025 China Medical Beauty Industry Chain Forum!  At this event, we will showcase our  Luer-lock prefillable syringe barrels(COP)  and  other high-end drug delivery devices.Discover how our innovations enhance precision, safety, and efficiency in medical beauty practices. Let’s shape the future of medical  beauty tech together! &nb...

     With the arrival of spring, thousands of peaks are beautiful, and the warm sun brings vitality to the entire country. On the afternoon of March 2nd, INNOPAC/BRAVO was invited to participate in the High-Quality Development Enterprise Commendation Conference and Smart Supply Chain Promotion Conference hosted by XinBang Town. Vice District Mayor Li...

Quality is the lifeline of an enterprise, the lifeblood and soul of an enterprise. In order to further standardize the company's business processes, effectively control risks, and form a standardized operation and standardized management model, Shanghai Bellerive started to implement ISO9001 quality management system certification at the beginning of 2022, and passed ISO9001/ISO13485 ...